Home›Stocks›IOVA

IOVA — structural market context

Iovance Biotherapeutics, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $14.62 (Oct 21) vs $14.86 (Oct 20): −1.62%.

Volume

0.65× its 20-session average (16.9M) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 64.8M shares (settlement Sep 30) vs 87.1M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 6 days with fails, largest 522K shares on Sep 30.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 1 day with fails, largest 2K shares on Sep 4.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

IOVA short interest & days to cover

SHARES SHORT
64.8M
% OF FLOAT
16.4%
DAYS TO COVER
2.8
CHANGE VS PRIOR
-25.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

IOVA fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 22d522K$14.45
2026-09-29 · 23d234K$10.99
2026-09-28 · 24d2K$11

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

IOVA analyst ratings

FirmActionRatingPublished
BarclaysholdOverweight2026-10-13
Barclaysprice_target—2026-10-13
Robert W. Bairdprice_target—2026-10-08
Wells Fargoprice_target—2026-09-30
Wells FargoholdOverweight2026-09-30

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is IOVA's short interest?
As of the FINRA settlement date 2026-09-30, IOVA had 64.8M shares sold short — 16.4% of its float, with 2.8 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
What do analysts say about IOVA?
The most recent action: Barclays hold to Overweight on 2026-10-13. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell IOVA?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with I

IAG · IAMGold CorporationIBKR · Interactive Brokers Group, IncIBP · INSTALLED BUILDING PRODUCTS, IICL · ICL Group Ltd.IDT · IDT CorporationIDXX · IDEXX Laboratories, Inc.All I →

IOVA: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.